Starpharma

Sustainability Report and Carbon Intensity Rankings

Is Starpharma doing their part?

Their DitchCarbon score is 35

Starpharma has a DitchCarbon Score of 35 out of 100, indicating room for improvement in its sustainability practices. This score reflects a moderate level of carbon intensity in the company’s operations. To enhance its sustainability efforts, Starpharma needs to focus on reducing its carbon footprint and emissions.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Starpharma is part of the industrial manufacturing sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Starpharma, located in Australia, operates in a region with a very high carbon intensity rating. This suggests that the company’s sustainability efforts may be negatively impacted by the country’s overall high carbon emissions.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Starpharma

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

6.29%

...this company is doing 6.29% worse in emissions than the industry average.

Starpharma Holdings Limited, founded in 1996 and headquartered in Melbourne, operates within the industrial manufacturing sector, specifically focusing on the development of dendrimer products. As a leader in its field and part of the ASX 300, the company specializes in pharmaceutical, life science, and agrochemical applications. Starpharma offers a range of products and technologies, including the VivaGel® portfolio and DEP™ drug delivery systems, advancing its innovations through both internal development and commercial partnerships.

Compare Starpharma with other companies in the same industry –>

Bad news, Starpharma hasn't committed to SBTi goals yet

Starpharma has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining clear, science-based emissions reduction targets to align with global efforts to mitigate climate change.

Not participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.

Starpharma

Sustainability Report and Carbon Intensity Rankings

Is Starpharma doing their part?

Their DitchCarbon score is 35

Industry emissions intensity

Very low

Low

Medium

High

Very high

Location emissions intensity

Very low

Low

Medium

High

Very high

Unlock 30+ emissions intelligence data points

Unlock 30+ emissions data points on Starpharma

...this company is doing 6.29% worse in emissions than the industry average.

Bad news, Starpharma hasn't committed to SBTi goals yet

Claim this profile

Our methodology

Other company reports in this industry

Looking for a specific company?

Quicklinks

Resources

Get in touch